These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 400390)

  • 1. [Effect of potassium canrenoate on arterial pressure, plasma renin activity and urinary aldosterone in essential hypertension].
    Opocher G; Armanini D; Fallo F; Mantero F
    Boll Soc Ital Cardiol; 1978; 23(10):1757-66. PubMed ID: 400390
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interference of canrenoate potassium with plasma renin activity. Note I. Effects of canrenoate potassiumon plasma renin activity in patients with essential hypertension].
    Consolo F; Ferraù O; Pitrone F; Luzza G; Russo A; Virga T
    Boll Soc Ital Biol Sper; 1975 Dec; 51(24):1943-9. PubMed ID: 1231877
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension].
    Tosti-Croce C; Mantellini R; Fanti P; Sciarra F
    Minerva Med; 1983 Apr; 74(14-15):791-7. PubMed ID: 6339999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antihypertensive efficacy and effects on intra and extracellular electrolytes of a canrenoate potassium-butizide combination].
    Costa FV; Borghi C; Mussi A; Ambrosioni E
    Minerva Cardioangiol; 1988 Oct; 36(10):503-7. PubMed ID: 3226562
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy of canrenoate potassium in hypertensive cardiopathy. Clinical and echocardiographic evaluation].
    Caporicci D; Achilli L
    Minerva Cardioangiol; 1984 Sep; 32(9):581-7. PubMed ID: 6514202
    [No Abstract]   [Full Text] [Related]  

  • 6. Predicting interindividual variations in antihypertensive therapy: the role of sodium transport systems and renin.
    Niutta E; Cusi D; Colombo R; Pellizzoni M; Cesana B; Barlassina C; Soldati L; Bianchi G
    J Hypertens Suppl; 1990 Sep; 8(4):S53-8. PubMed ID: 2175354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Essential arterial hypertension. A therapeutic proposal].
    Di Veroli C; Iugoli AR
    Arch Sci Med (Torino); 1981; 138(3):355-60. PubMed ID: 6119065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical study of potassium canrenoate on raised intracranial pressure.
    Node Y; Nakazawa S
    Adv Neurol; 1990; 52():557. PubMed ID: 2396562
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of an aldosterone antagonist in abdominal surgery].
    Ribero F; Remonda G; Morachioli N; Pugnani M
    Ann Osp Maria Vittoria Torino; 1982; 25(1-6):61-70. PubMed ID: 7185311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic report on an injectable aldosterone antagonist (K-canrenoate) in states of water-salf retention].
    Coltorti M; Radaeli E; Ciaccio S; Corsini R; Trebbi R
    Clin Ter; 1976 Feb; 76(3):215-34. PubMed ID: 963962
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in nitrogen balance during the period following abdominal surgery and use of an injectable anti-aldosterone].
    Metivier Y; Guinot P; Saizy R; Meillaud J; Lioret N
    Agressologie; 1976; 17(5):313-8. PubMed ID: 1015551
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic effect of canrenoate potassium (soldactone) in patients after open-heart surgery].
    Matsuda K; Tatsuta N; Konishi Y; Minami K; Nishiwaki N; Yamasato A; Chiba Y; Ishihara H; Murata S; Shiraishi Y; Muraguchi T; Hikasa Y
    Nihon Geka Hokan; 1982 May; 51(3):519-27. PubMed ID: 7138201
    [No Abstract]   [Full Text] [Related]  

  • 13. [Brain edema in neurosurgery. Trial with an aldosterone-antagonist (soldactone) (author's transl)].
    Anderes JP; de Tribolet N; Zander E
    Schweiz Rundsch Med Prax; 1977 Aug; 66(32):1020-6. PubMed ID: 556440
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of digitalis toxicity with intravenous potassium canrenoate.
    Gavrilescu G; Cristodorescu R; Deutsch G; Berger E
    Agressologie; 1977; 18(3):167-71. PubMed ID: 920909
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of plasma renin activity and urinary excretion of aldosterone in patients with essential hypertension treated with D-L propranolol].
    Bompiani GD; Scaduto P; Galluzzo A; Morici ML; Mangano MT; Donatelli M
    Minerva Cardioangiol; 1976; 24(7-8):498-505. PubMed ID: 1018743
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of the plasma renin activity and urinary aldosterone excretion in patients with essential hypertension treated with spironolactone. Note II].
    Bompiani GD; Scaduto P; Galluzzo A; Donatelli M; Morici ML; Mangano MT; Messina L
    Minerva Cardioangiol; 1976 May; 24(5):352-9. PubMed ID: 1012481
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of canrenoate potassium given orally in ascitogenic cirrhosis].
    Sarti F; Milandri GL; Piemontese A; Macchia S; Simoni S; Dal Monte PR
    Minerva Dietol Gastroenterol; 1984; 30(3):273-80. PubMed ID: 6504377
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].
    Tempini S; Bellati G; Ideo G
    Minerva Dietol Gastroenterol; 1984; 30(3):255-61. PubMed ID: 6504374
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of potassium canrenoate in cardiosurgery].
    Tufano R; Scopa M; Brando G; Leone D
    Minerva Anestesiol; 1981 Apr; 47(4):149-54. PubMed ID: 7242963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonidine in primary hypertension: effects on blood pressure, plasma renin activity, plasma and urinary aldosterone.
    Karlberg BE; Nilsson O; Tolagen K
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):10-20. PubMed ID: 401703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.